Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baudouin Standaert

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Public Health|November 27, 2010
A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancerNadia Demarteau, Bruno Detournay, Bertrand Tehard, et al.
Vaccine|August 29, 2018
Preferences for vaccines against children's diarrheal illness among mothers in Poland and HungaryChristine Poulos, Baudouin Standaert, Brigitte Sloesen, et al.
Journal of Infection and Public Health|February 19, 2017
Economic assessment of rotavirus vaccination in Saudi ArabiaAmal Y A Al-Aidaroos, Baudouin Standaert, Kinga Meszaros, et al.
Journal of Market Access & Health Policy|August 9, 2021
Informing decision makers seeking to improve vaccination programs: case-study SerbiaChristophe Sauboin, Jovan Mihajlović, Maarten Jacobus Postma, et al.
Health Policy (Amsterdam, Netherlands)|October 29, 2017
Optimising the introduction of multiple childhood vaccines in Japan: A model proposing the introduction sequence achieving the highest health gainsBaudouin Standaert, Nadia Schecroun, Olivier Ethgen, et al.
Vaccine|July 21, 2009
Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countriesLisandro Colantonio, Jorge A Gómez, Nadia Demarteau, et al.
Value in Health Regional Issues|April 13, 2021
Constrained Optimization for Pneumococcal Vaccination in BrazilJan Olbrecht, Jorge A Gomez, Laure-Anne Van Bellinghen, et al.
Vaccine|January 25, 2008
The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the NetherlandsLucas M A Goossens, Baudouin Standaert, Nico Hartwig, et al.
Journal of Market Access & Health Policy|March 5, 2020
How to assess for the full economic value of vaccines? From past to present, drawing lessons for the futureBaudouin Standaert, Christophe Sauboin, Rodrigo DeAntonio, et al.
Plos One|January 26, 2013
Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed dataBaudouin Standaert, Jorge A Gomez, Marc Raes, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Public Health|November 27, 2010
A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancerNadia Demarteau, Bruno Detournay, Bertrand Tehard, et al.
Vaccine|August 29, 2018
Preferences for vaccines against children's diarrheal illness among mothers in Poland and HungaryChristine Poulos, Baudouin Standaert, Brigitte Sloesen, et al.
Journal of Infection and Public Health|February 19, 2017
Economic assessment of rotavirus vaccination in Saudi ArabiaAmal Y A Al-Aidaroos, Baudouin Standaert, Kinga Meszaros, et al.
Journal of Market Access & Health Policy|August 9, 2021
Informing decision makers seeking to improve vaccination programs: case-study SerbiaChristophe Sauboin, Jovan Mihajlović, Maarten Jacobus Postma, et al.
Health Policy (Amsterdam, Netherlands)|October 29, 2017
Optimising the introduction of multiple childhood vaccines in Japan: A model proposing the introduction sequence achieving the highest health gainsBaudouin Standaert, Nadia Schecroun, Olivier Ethgen, et al.
Vaccine|July 21, 2009
Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countriesLisandro Colantonio, Jorge A Gómez, Nadia Demarteau, et al.
Value in Health Regional Issues|April 13, 2021
Constrained Optimization for Pneumococcal Vaccination in BrazilJan Olbrecht, Jorge A Gomez, Laure-Anne Van Bellinghen, et al.
Vaccine|January 25, 2008
The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the NetherlandsLucas M A Goossens, Baudouin Standaert, Nico Hartwig, et al.
Journal of Market Access & Health Policy|March 5, 2020
How to assess for the full economic value of vaccines? From past to present, drawing lessons for the futureBaudouin Standaert, Christophe Sauboin, Rodrigo DeAntonio, et al.
Plos One|January 26, 2013
Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed dataBaudouin Standaert, Jorge A Gomez, Marc Raes, et al.
Pageof 6